About the Authors
- Anna M Vogt
-
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
- Fredrik Pettersson
-
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
- Kirsten Moll
-
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
- Cathrine Jonsson
-
Affiliation Department of Nuclear Medicine, Karolinska University Hospital, Solna, Sweden
- Johan Normark
-
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
- Ulf Ribacke
-
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
- Thomas G Egwang
-
Affiliation Med Biotech Laboratories, Kampala, Uganda
- Hans-Peter Ekre
-
Affiliation Dilafor AB, Stockholm, Sweden
- Dorothe Spillmann
-
Affiliation Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
- Qijun Chen
-
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
- Mats Wahlgren
-
*To whom correspondence should be addressed. E-mail: mats.wahlgren@ki.se
Affiliation Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden and Swedish Institute for Infectious Disease Control, Solna, Sweden
Competing Interests
The authors declare competing financial interest. AMV, MW, and HPE hold stock and/or stock options in Dilafor AB, which owns the intellectual property of the substances generated in this manuscript. AMV has received research funding from Dilafor AB. The remaining authors have no known financial interest.
Author Contributions
AMV and MW designed the study. FP developed the monkey model. AMV performed the experiments with contributions to the laboratory work from FP, KM, DS, and QC. AMV and FP analyzed the data. CJ generated computer programs for the collection of data. JN, UR, and TGE collected the patient samples. The employer of HPE produced GMP material. AMV and MW wrote the report with assistance from the co-authors.